hematopoietic stem cell data for autologous hematopoietic stem cell mobilizatio
- Conditions
- Neoplasms
- Registration Number
- KCT0009037
- Lead Sponsor
- lsan Univeristy Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 50
? Patients who voluntarily signed the consent form for participation in this clinical trial
? Patients with Lymphoma who used Neurapec (pegteograstim) during previous chemotherapy
? Patients with multiple myeloma who have never used Neurapec (pegteograstim) during previous chemotherapy
? patients with hematologic malignancy undergoing autologous hematopoietic stem cell mobilization as subjects for autologous hematopoietic stem cell transplantation
? Subjects who do not agree with the prospective observational study
? Patients who have previously used pegylated GCSF other than Neurapec
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method CD34+ cell counts, Hematopoietic progenitor cell , CPD item, ImmNeIndex
- Secondary Outcome Measures
Name Time Method